Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
576.88B | 578.56B | 578.56B | 529.67B | 412.72B | 490.42B | Gross Profit |
107.32B | 95.93B | 102.34B | 92.11B | 61.20B | 81.04B | EBIT |
47.04B | 38.87B | 46.99B | 36.98B | 10.07B | 24.77B | EBITDA |
106.72B | 75.96B | 83.11B | 68.56B | 37.99B | 47.52B | Net Income Common Stockholders |
52.19B | 30.55B | 36.30B | 26.89B | 4.52B | 10.99B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
51.41B | 46.01B | 58.22B | 58.14B | 67.31B | 59.56B | Total Assets |
820.67B | 788.73B | 773.85B | 728.19B | 665.51B | 625.90B | Total Debt |
216.52B | 176.23B | 234.29B | 226.47B | 197.36B | 192.44B | Net Debt |
165.11B | 130.22B | 176.06B | 168.33B | 130.05B | 132.88B | Total Liabilities |
353.56B | 331.42B | 368.38B | 363.18B | 326.15B | 316.76B | Stockholders Equity |
427.14B | 418.56B | 368.72B | 329.71B | 303.14B | 273.56B |
Cash Flow | Free Cash Flow | ||||
-16.00M | 17.88B | 1.18B | -35.75B | 5.95B | -4.38B | Operating Cash Flow |
10.09B | 50.24B | 22.63B | -16.68B | 33.77B | 41.03B | Investing Cash Flow |
-10.46B | 13.62B | -20.08B | -14.57B | -29.39B | -39.33B | Financing Cash Flow |
7.24B | -76.48B | -2.67B | 19.40B | 3.00B | 10.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
€1.32B | 7.30 | 6.56% | 4.84% | ― | ― | ||
51 Neutral | $2.02B | -1.14 | -21.37% | 3.64% | 2.88% | -30.57% | |
$1.12B | 7.37 | 10.08% | 3.46% | ― | ― | ||
$1.11B | 12.67 | 6.92% | 5.97% | ― | ― | ||
€925.00M | 19.57 | 3.23% | 2.08% | ― | ― | ||
75 Outperform | ¥256.05B | 10.52 | 3.68% | -3.56% | 3.19% | ||
57 Neutral | ¥103.65B | 32.12 | 1.28% | -0.60% | 3.40% |